BLOG   |   CAREERS   |   E-MAGAZINE   |   Contact Us   |   Sign In   |   Join
Clinical Guidance

 

                 

     










 H. Jeffrey Kim, MD 
Georgetown MedStar Health 
CI2015DC Emerging Issues in Cochlear Implantation

 



Advances in Candidacy, Technology, and Outcomes

Cochlear Implants 2016: Advances in Candidacy, Technology, and Outcomes, Factors That Drive the Expansion of Pediatric Cochlear Implant Candidacy by Terry Zwolan and Donna Sorkin was published by ASHA’s Special Interest Group on Hearing and Hearing Disorders in Childhood, SIG 9, Vol. 1(Part 1), 2016.  It reviews recent progress made in cochlear implant technology, effects of early intervention, better understanding of the impact of residual hearing, and resultant changes in pediatric candidacy criteria and outcomes.

This is intended as a helpful paper to share with non-CI clinicians, early intervention personnel, educators, pediatricians, parents and others who interact with families of children with hearing loss.

Contact Susan Thomas (sthomas@acialliance.org) if you would like to receive a copy of this paper.

ACI Alliance Issues Pediatric Habilitation Position Paper

Background

American Cochlear Implant Alliance advocates for access to the continuum of cochlear implant care, which includes (re)habilitation needed for a child or an adult. Our State Champions assessed coverage of cochlear implantation under Affordable Care Act Marketplace plans. We found that CI was a covered service in nearly every plan we looked at. However, we had concerns relating to limitations on the number of therapy sessions allowed under such plans, which typically were limited to 30 sessions per year—regardless of the age of the patient. Such limits are often referred to as "therapy caps” and are increasingly common in private insurance plans.

Position Paper

The Board of Directors of ACI Alliance appointed a committee of therapeutic clinicians to develop a position paper on pediatric habilitation following cochlear implantation. The committee was encouraged to utilize an evidence-based approach and provide a document that would be helpful in documenting the need for appropriate habilitation post cochlear implantation. The attached Position Paper was authored by Hannah Eskridge, Amy McConkey Robbins, Kathryn Wilson, and Lindsay Zombek and approved by the ACI Alliance Board of Directors. We are grateful to the committee for this significant contribution to our field. Position Paper: Pediatric Habilitation Following Cochlear Implantation.

How to Use the Position Paper

We intend for this paper to be utilized as a resource for health insurance providers (both public and private plans), early intervention professionals, families, pediatricians, and others involved in ensuring appropriate speech-language services for children with hearing loss. It may also be helpful to reference the Cochlear Implant Continuum of Care, available on our website under Cochlear Implant Information. We welcome your feedback on the Position Paper and your ideas for other position statements that may improve access to cochlear implant care.

 

Bilateral Cochlear Implantation 

Position Statement on Bilateral Cochlear Implantation

Read more here: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701670/

April 2013 -American Cochlear Implant Alliance Posts comments for Washington State Technology Assessment of Bilateral Cochlear Implants

The Alliance filed follow-up comments on the efficacy of Bilateral Cochlear Implants for people with hearing loss. http://www.acialliance.org/page/AdvocacyInitiatives

 

Adult Pneumococcal Meningitis Vaccination

December 2012 - Revised Recommendation for Pneumococcal Meningitis Vaccination for Adult Cochlear Implant Recipients

The Centers For Disease Control has recently revised the recommendation for pneumococcal meningitis vaccination for adult cochlear implant recipients. These recommendations were revised after recent studies on vaccine effectiveness in immunocompetent patients indicated that a change to the vaccine regimen may prove to be even more effective in preventing meningitis in these groups.

Read More

 The Center for Disease Control provides Q &A for Health Care Professionals: Persons with cochlear implants should be considered high-risk for pneumococcal meningitis. To help prevent meningitis for this group, consider the questions listed HERE.

CDC Position Statement: Immunizations Recommendations for Cochlear Implant PatientsGuidelines provided by the Centers for Disease Control and Prevention (CDC) recommending the importance of age-appropriate immunizations against specific organisms that cause meningitis in patients who have, or will receive a cochlear implant.

The Importance of Vaccinations in Cochlear Implant Users: The Children's Cochlear Implant Center at UNC School of Medicine provides information regarding the two types of pneumococcal vaccine and the immunization schedules for children.

Membership Management Software Powered by YourMembership  ::  Legal